A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)
This study has been completed.
First Posted: March 7, 2006
Last Update Posted: February 27, 2014
Information provided by (Responsible Party):